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Abstract
Inflammatory cell migration characteristic of ischemic damages has a dual role providing the tissue with factors needed for
tissue injury recovery simultaneously causing deleterious development depending on the quality and the quantity of
infiltrated cells. Extracellular superoxide dismutase (SOD3) has been shown to have an anti-inflammatory role in ischemic
injuries where it increases the recovery process by activating mitogen signal transduction and increasing cell proliferation.
However, SOD3 derived effects on inflammatory cytokine and adhesion molecule expression, which would explain reduced
inflammation in vascular lesions, has not been properly characterized. In the present work the effect of SOD3 on the
inflammatory cell extravasation was studied in vivo in rat hind limb ischemia and mouse peritonitis models by identifying
the migrated cells and analyzing SOD3-derived response on inflammatory cytokine and adhesion molecule expression.
SOD3 overexpression significantly reduced TNFa, IL1a, IL6, MIP2, and MCP-1 cytokine and VCAM, ICAM, P-selectin, and E-
selectin adhesion molecule expressions in injured tissues. Consequently the mononuclear cell, especially CD68+ monocyte
and CD3+ T cell infiltration were significantly decreased whereas granulocyte migration was less affected. According to our
data SOD3 has a selective anti-inflammatory role in ischemic damages preventing the migration of reactive oxygen
producing monocyte/macrophages, which in excessive amounts could potentially further intensify the tissue injuries
therefore suggesting potential for SOD3 in treatment of inflammatory disorders.
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Introduction
The inflammatory process is initiated by endothelial cell (EC)
activation comprising upregulation of chemokines and cell
adhesion molecules, leukocyte activation and transmigration,
and secretion of proinflammatory factors by leukocytes [1]. The
inflammatory reaction is necessary for tissue recovery as it
provides the correct cytokine signals and cell machinery to clear
up the site for regeneration of the tissue [2]. However,
uncontrolled inflammation has unfavorable effects on the course
of tissue healing since the inflammatory cells are also capable of
inducing tissue damage [2] and therefore many conditions
involving inflammation, e.g. autoimmune diseases and tissue
transplantations, are treated with immunosuppressants to reduce
harmful leukocyte infiltration. Among the most potent drugs are
glucocorticoids that downregulate the expression of numerous
inflammatory chemokines, cytokines and adhesion molecules [3–
5], which, however, are not entirely without adverse effects such as
delayed myocardial tissue healing, osteoporosis, and blood vessel
calcification [6–9].
The most prominent outcome in the initial phase of
inflammation is the enhanced production of cytokines, such as
TNF-a and IL-1, and chemokines, such as monocyte chemoat-
tractant protein-1 (MCP-1) [10,11], which further induce
expression of a number of inflammatory cytokines [4]. Many of
the stimulus-specific pathways converge in the production of
superoxide (O2
2) and hydrogen peroxide (H2O2) as signal
mediators, which in turn result in e.g. NFkB activation responsible
for numerous stress-related functions [12–14]. Leukocytes are thus
recruited by expression of various cell adhesion molecules, e.g.
selectins, and intercellular and vascular cell adhesion molecules
(ICAM-1 and VCAM-1, respectively) [15,16]. They promote
rolling and firm adhesion of leukocytes to endothelial wall, the
necessary interactions preceding transmigration [17]. To aid
leukocyte migration the vessel wall cells change their morphology
by assuming cytoskeletal and cell-cell junction modifications in
response to e.g. ligand binding to ICAM-1 and VCAM-1 [18–20],
and when stimulated by O2
2 or TNF-a [21,22].
Previously, it has been shown that extracellular superoxide
dismutase (SOD3) can attenuate tissue damage and inflammation
but so far its mechanism of action has not been completely defined
[23–27]. Since excess inflammation prevents the tissue injury
recovery we investigated in the present study the effect of SOD3
overexpression on cell migration. We used two in vivo acute
inflammation models to determine how SOD3 affects leukocyte
extravasation, and compared the results to efficacy of the
glucocorticoid immunosuppressant dexamethasone. The mouse
peritonitis and rat hind limb ischemia models have been
characterized previously: they induce rapid infiltration of leuko-
cytes to the peritoneal cavity and large femoral muscles,
PLoS ONE | www.plosone.org 1 June 2009 | Volume 4 | Issue 6 | e5786respectively [28–30]. We then analyzed the proportions of the
infiltrated leukocyte subtypes, and determined the effects on
several mediators of the inflammatory reaction.
Materials and Methods
Ischemia model
Fischer 344 rats (Harlan, Horst, Netherlands) and Balb/C mice
(local colony) were maintained in specific pathogen-free conditions
and had access to food and water ad libitum. All experimental
procedures were approved by the Experimental Animal Commit-
tee of University of Turku.
Ischemic hind limb injury was induced to male Fischer 344 rats
(5 to 6 weeks old, 86–115 g) by surgical closure of the distal
femoral artery, lateral circumflex femoral artery, and the proximal
femoral artery. The animals were anesthetized for the procedure
by intra peritoneal administration of fentanyl fluanisone (Janssen
Pharmaceutica, Beerse, Belgium) and midazolame (Roche, Basel,
Switzerland). Gene transfer was done immediately after the
ligation by intra muscular injection of 0.5610
9 pfu adenovirus
SOD3 (AdSOD3) or LacZ (AdLacZ) in 50 ml PBS as described
[27,31,32]. Uninjured muscle tissue was used as control.
Peritonitis model
Gene transfer wasdone to 8–10 week old femalebalb/c micewith
intra peritoneal injection of 0.5610
9 pfu AdSOD3 or AdLacZ.
Acute peritoneal inflammation was induced 72 hours later by i.p.
injection of 1 ml PBS containing 5% proteose peptone (BD Difco,
Sparks, MD, USA) and 10 ng of IL-1b (R&D Systems, Minneapolis,
MN, USA). As a control treatment, animals were given 50 mg/kg of
Dexamethasone (Oradexon, Organon, Oss, Holland) half an hour
before proteose peptone injection. Cells from the peritoneal cavity
were collected 18 hours after the induction of inflammation by
washing with 10 ml of RPMI containing 5 U/ml heparin (Løvens
Kemiske Fabrik, Ballerup, Denmark). Cells from peritoneal lavage
were counted and cytocentrifuged at 1000 rpm for 5 minutes
(Shandon cytospin 3, Shandon, Pittsburgh, PA, USA). Slides were
stained with Reastain Diff-Quick (Reagena, Toivala, Finland) to
analyze different leukocyte subtypes.
Immunohistochemistry
Rat muscle samples were frozen in liquid nitrogen and
embedded in Tissue-Tek optimal cutting temperature compound
(Sakura Finetek, Torrance, CA, USA). Ten micrometer sections
were fixed in acetone and stained with rabbit anti-rat CD3 and
mouse anti-rat CD68 (Serotec, Oxford, UK). The sections were
counterstained with hematoxylin/eosin (Sigma, Saint Louis, MI,
USA). The number of CD3
+ and CD68
+ cells were analyzed from
whole sections with Zeiss Axiovert 200 M (Carl Zeiss, Oberko-
chen, Germany).
Reporter assay
HEK 293T cells were used for in vitro assay to provide a general
cell model that we have previously used in our reporter,
expression, and cell signalling studies allowing the comparison of
the data with our previous results. HEK 293T cells were
transfected with SOD3 expression vector together with pNFkB
Luc reporter (Stratagene, Cedar Creek, TX, USA). Luciferase
activity was quantified with Tecan Ultra XFluor4 Fluorescence
Reader (Tekan, Mannedorf, Switzerlard).
Western blot analysis
HEK293 cells were homogenized in lysis buffer (50 mmol/l
HEPES pH 7.5, 150 mmol/l NaCl, 10% glycerol, 1% Triton X-
100, 1 mmol/l MgCl, 10 mmol/l NaF, 10 mmol/l sodium
pyrophosphate, 1 mmol/l Na3VO4,1 0mg/ml approtinin, 10 mg/
ml leupeptin) (Sigma, Saint Louis, MI, USA). Mouse anti-human a-
IkB (Santa Cruz, Santa Cruz, CA, USA) was used to detect IkB
levels from tissues.
Quantitative PCR
Total RNA was extracted from a pool of four animals using Tri-
reagent (Sigma, Saint Louis, MI, USA). The first strand synthesis
was done with Revert-Aid M-MuLV (Fermentas, Burlington,
Canada), and the following quantitative PCR with SYBR Green
PCR master mix (Applied Biosystems, Foster City, CA). Primers
and cycling conditions are shown in the Table 1.
Statistical Analysis
All results are expressed as mean6SEM. A paired t-test was
used to determine differences between groups.
Results
SOD3 inhibits leukocyte migration in acute ischemia
Neutrophils, macrophages, and other inflammatory cells
mediate a number of important cellular functions in injured tissue
[33,34]. Phagocytotic macrophages clear cellular debris and
secrete inflammatory cytokines such as MIP-2, a strong neutrophil
attracting agent leading to further increase in inflammatory
signaling [35]. However, excessive inflammatory reaction may also
contribute to tissue damage by enhancing macrophage infiltration,
which increases tissue free radical load leading to further tissue
injury [36]. In addition, decreased neutrophil accumulation leads
to reduced infarct size, reduced vascular permeability, and
resistance in ischemia/reperfusion (I/R) injury [37,38]. Thus, it
is suggested that the tissue recovery is dependent on the factors
Table 1. Primers and cycling conditions.
Gene Primer Tm
TNFa for AGA TGT GGA ACT GGC AGA GG 60
TNFa rev CCC ATT TGG GAA CTT CTC CT
IL-1a for TCG GGA GGA GAC GAC TCT AA 58
IL-1a rev GAA AGC TGC GGA TGT GAA GT
IL-6 for CCG GAG AGG AGA CTT CAC AG 55
IL-6 rev ACA GTG CAT CAT CGC TGT TC
MCP-1 for CTC ACC TGC TGC TAC TCA TTC ACT 55
MCP-1 rev TGC TGC TGG TGA TTC TCT TGT AGT
MIP2 for ATC CAG AGC TTG ACG GTG AC 55
MIP2 rev GGA CTT GCC GCT CTT CAG TA
ICAM for AGG TAT CCA TCC ATC CCA CA 55
ICAM rev GCC ACA GTT CTC AAA GCA CA
VCAM for TGA CAT CTC CCC TGG ATC TC 55
VCAM rev CTC CAG TTT CCT TCG CTG AC
PSEL for TTC CCA CAC TTC CTT CTG CT 57
PSEL rev CAC GCT GTA GTC GGG GTA TT
ESEL for TTT TTG GCA CGG TAT GTG AA 57
ESEL rev AGG TTG CTG CCA CAG AGA GT
b-actin for TCG TGC GTG ACA TTA AGG AG 55
b-actin rev GTC AGG CAG CTC GTA GCT CT
doi:10.1371/journal.pone.0005786.t001
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present work we studied leukocyte migration in acute ischemia and
peritonitis models and analyzed the contribution of SOD3 on
inflammatory cytokine and adhesion molecule expression.
We determined the effect of SOD3 overexpression on the
degree of inflammation by analyzing the size of inflamed tissue
and the number of infiltrated macrophages and T cells in acute
ischemic injury model. In a mouse model of femoral artery
ligation, macrophage infiltration into ischemic muscle reaches
peak values 3 days after the injury [39]. Histological analysis of the
rat hind limb ischemia showed 3-fold reduction in the inflamed
tissue area as determined by the presence of CD68
+ macrophages
(p,0.001) in SOD3 vs. LacZ control animals 3 days after vessel
ligation (Figure 1). The reduction became even more prominent in
later time points reaching 12-fold difference 10 days after vessel
ligation. Additionally, the number of infiltrated CD68
+ macro-
phages was 3–5 fold higher in LacZ control animals as compared
to SOD3 animals (p,0.05). Maximal macrophage accumulation
to the injured tissue was seen at 7-day time point in LacZ animals
indicating that the inflammatory reaction was still developing in
control animals at the initial phase of the follow-up period while
the inflammation was decreasing in SOD3 animals. Throughout
the experiment the number of macrophages remained higher in
control animals than initially observed in SOD3 animals, which by
the 10-day time point showed values close to the background levels
further underlining the beneficial effect of SOD3.
Figure 1. Reduced macrophage infiltration in to ischemic muscle. Open bars represent LacZ animals and black bars represent SOD3 animals.
CD68 staining showed significantly reduced inflammatory area and macrophage infiltration in SOD3 animals at all time points studied. Histological
stainings show CD68+ macrophages around the femoral artery in ischemic muscles (206magnification).
doi:10.1371/journal.pone.0005786.g001
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PLoS ONE | www.plosone.org 3 June 2009 | Volume 4 | Issue 6 | e5786Figure 2. Inhibition of T-cell migration. Open bars represent LacZ animals and black bars represent SOD3 animals. Infiltration of CD3+
lymphocytes was inhibited in SOD3 animals 10 days after injury remaining at the level seen at earlier 3-day time point (206magnification).
doi:10.1371/journal.pone.0005786.g002
Figure 3. Anti-inflammatory effect of SOD3 affects predominantly macrophages in peritonitis model. Open bars represent LacZ animals
and black bars represent SOD3 animals. (a) SOD3-mediated reduction in total leukocyte number in peritoneal lavage 18 hours after induction of
inflammation. SOD3 treated animals had 55.6610
4 (64.1) cells/milliliters of lavage as compared to 91.6610
4 (66.7) found from LacZ control animals.
(b) Analysis of different leukocyte subtypes showed strongest effect in macrophages although lymphocyte migration was also reduced. Monocyte
accumulation in LacZ vs. SOD3 treatment was reduced from 33.5610
4 (61.8) to 10.9610
4 (62.5) cells/ml whereas lymphocytes were reduced from
11.4610
4 (62.2) to 7.6610
4 (61.2) cells/ml, and neutrophils from 47.0610
4 (64.7) to 37.5610
4 (62.9) cells/ml.
doi:10.1371/journal.pone.0005786.g003
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+
T-cells in recovery of ischemic tissue has remained uncertain.
Despite relatively low level of infiltration, studies suggest an early
role for T-cells in attracting neutrophils and macrophages to site of
myocardial or peripheral ischemia/reperfusion injury [40,41].
The histological analysis at 3-day time point showed 114623 and
153646 (p=ns.) CD3
+ T cells per ischemic tissue section in
SOD3 and LacZ animals, respectively (Figure 2). At 10-day time
point number of T cells had increased in LacZ animals by 60% to
247631 whereas in SOD3 animals T cell accumulation remained
at similar level as compared to 3 day time point (125630,
p,0.05). The analysis of leukocyte accumulation in the rat hind
limb ischemia model shows selective inhibition of inflammatory
cell migration and suggests SOD3 to have more prominent effect
on macrophage infiltration as compared to lymphocytes.
SOD3-mediated inhibition of leukocyte accumulation in
peritonitis model
To confirm the findings and to further analyze the SOD3-derived
selective inhibition of cell migration we examined leukocyte
migration in a mouse peritonitis model, which provides an efficient
way to analyze leukocyte traffic in an acute inflammatory response.
To induce peritoneal inflammation we used 5% solution of proteose
peptone supplemented with IL-1b and counted the numbers of
different leukocyte subtypes from the peritoneal lavage 18 hours
after induction of inflammation. The analysis of SOD3 overexpres-
sion derived inhibition of cell migration showed 20% (p=ns), 67%
(p,0.001), and 33% (p,0.05) reduction in migrating neutrophils,
monocytes/macrophages,andlymphocytes,respectively(Figure3B).
Moreover, the total number of infiltrated leukocytes was decreased
by 30% in SOD3 animals as compared to LacZ controls (Figure 3A)
(p,0.01), which is mostly caused by the effect of attenuated
macrophage migration. The data effectively confirmed our findings
in rat hind limb ischemia showing vastly stronger inhibition of
macrophage infiltration as compared to other leukocyte subtypes.
Dexamethasone, a corticosteroid that reduces swelling and
inflammation is a potent anti-inflammatory drug used to treat
many bacteria-free inflammatory conditions, including rheuma-
toid arthritis and anaphylactic shock. Glucocorticoids exert their
anti-inflammatory effect e.g. through repression of NF-kB
mediated cytokine expression, which takes place after cytoplasmic
glucocorticoid receptor translocates into the nucleus [5,42]. To
compare SOD3 to clinically approved medication we gave an
intra-peritoneal injection of dexamethasone (Oradexon) to animals
30 minutes before induction of peritoneal inflammation. Leuko-
cyte traffic to the inflamed peritoneum was reduced by 20%
(p,0.05) after treatment with 50 mg/kg dexamethasone
(Figure 4A). Monocyte/macrophage migration was reduced by
60% (p,0.01), and that of lymphocytes by marked 50% indicating
tendency, while no significant difference was seen in neutrophil
accumulation in this setting (Figure 4B). PBS mock treated animals
exhibited lower neutrophil and monocyte accumulation as
compared to animals subjected to LacZ gene transfer, which
may be result of the adenovirus vector used in the study.
Intriguingly, SOD3 treatment reduced peritoneal monocyte and
lymphocyte numbers to similar level as dexamethasone treatment
although neutrophil numbers remained higher than what was
observed in either PBS or dexamethasone treated animals.
SOD3 inhibits NF-kB activation and suppresses the
inflammatory cytokine and adhesion molecule
expression
Proinflammatory stimuli activate vascular endothelium leading
to up-regulation of cell adhesion molecules and chemokines, NF-
kB has been shown to be both necessary and sufficient for
endothelial up-regulation of ICAM, VCAM, and MCP-1 [43].
Furthermore, ectopic expression of IkBa effectively abrogates
expression of VCAM, IL-1, and IL-6 [44]. In vitro luciferase assay
revealed 50% (p,0.01) decrease in NF-kB activity due to SOD3
transfection, which could at least partially be explained by
increased IkBa expression (Figure 5A) suggesting that SOD3
promotes cytoplasmic localization of NF-kB rendering it incapable
of binding DNA. NF-kB plays a central part in responses to
inflammatory signaling by regulating the expression of cytokines
suggesting that reduced NF-kB activity could lead to reduction in
expression of inflammatory cytokines and chemokines. Therefore,
we quantified cytokine and chemokine expression level in vivo from
rat muscle three days after vessel ligation and SOD3 gene transfer.
Quantitative RT-PCR showed significantly reduced expression of
TNFa, IL1a, IL6, MIP2, and MCP1 (Figure 5B) in SOD3 animals
suggesting reduced expression of several important inflammatory
mediators. Specifically, MCP1 is an important macrophage
Figure 4. Anti-inflammatory effect of dexamethasone. Open bars represent PBS treated animals and black bars represent dexamethasone
animals (dosage 50 mg/kg). (a) Leukocyte infiltration was reduced by dexamethasone treatment from 51.5610
4 (64.7) to 36.5610
4 (67.1) cells/
milliliters of lavage. (b) Dexamethasone treatment had no effect on neutrophil migration, 16.6610
4 (62.9) and 21.5610
4 (65.2) cells/ml were found in
PBS control group and dexamethasone treated animals, respectively. In contrast, accumulation of monocytes and lymphocytes were reduced from
21.4610
4 (62.7) to 8.8610
4 (62.2), and from 13.7610
4 (63.2) to 6.5610
4 (62.4), respectively.
doi:10.1371/journal.pone.0005786.g004
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phage accumulation. Furthermore, since TNFa, IL1a, and IL6
are important regulators of endothelial adhesion molecule
expression we analyzed expression of ICAM, VCAM, E-selectin,
and P-selectin from the tissue (Figure 5C). We found significant
reduction in adhesion molecule expression, which further confirms
the reduction in overall inflammation in the muscle of SOD3
recipient rats as compared to LacZ control animals.
Discussion
Tissue damage launches rapid recruitment of inflammatory
leukocytes into injured tissue due to activation of endothelial cells.
Inflammatory reaction promotes tissue healing by eliminating
pathogens, clearing cellular debris, and promoting cell prolifera-
tion. However, excessive inflammatory reaction promotes injury
e.g. through neutrophil-derived superoxide production [47]. In
fact, reactive oxygen species function as inflammatory mediators
by activating expression of cytokines such as TNFa, IL-1, and IL-6
[48] and therefore ROS may contribute to tissue injury by not
only directly damaging the tissue but also by enhancing further
leukocyte accumulation.
In the current work we showed that SOD3 is an important
mediator of reduced CD68+ macrophage migration into the
inflammatory area. Macrophages accumulate in high numbers to
ischemic muscleforming the primary leukocyte population three days
after injury [39]. CD68 staining showed significantly reduced
inflammatory area and macrophage migration in SOD3 treated
ischemic tissue as compared to LacZ control animals (Figure 1). The
SOD3-mediated reduction in macrophage accumulation was evident
in all of the studied time points. T-cells accumulate to ischemic
muscle in vastly lower numbers as compared to macrophages.
However, their presence is required for efficient neutrophil traffic,
and they attract macrophages by secreting IL-16 [40]. In our studies,
SOD3 didnot prevent initial low level T-cell migration, but efficiently
inhibited further increase at 10-day time point (Figure 2). Late effect
on T-cell migration suggests an indirect mechanism for SOD3
mediated inhibition in T-cell traffic, which might be result of general
decrease in inflammation. Inflammatory cytokines secreted by
infiltrating macrophages attract other leukocytes to injured tissue
[49]. Thereafter, inhibition of macrophage infiltration could lead to
overall reduction in inflammatory reaction.
Since the SOD3-derived reduction in inflammation showed
selective inhibition of macrophage migration, we were prompted
to confirm the finding and to better characterize the cell specific
effect. The mouse peritonitis model supported the SOD3-derived
reduction in the number of infiltrating leukocytes (Figure 3A),
which was predominantly due to reduced macrophage numbers
(Figure 3B). These results confirm the anti-inflammatory property
of SOD3 and show a stronger inhibition of monocyte migration as
compared to other analyzed leukocyte subtypes. The data suggest
that reduced superoxide tissue concentrations caused by SOD3
overexpression may explain the anti-inflammatory effect of the
enzyme. It has been previously shown that superoxide treatment of
rat cerebral endothelial cells increases monocyte adhesion and
migration, which, however, was not replicated by H2O2 treatment
but was instead abrogated by superoxide scavengers suggesting
superoxide as an inflammatory mediator [21]. We have shown in
our previous works that SOD3 overexpression in vivo efficiently
decreases the production of superoxide in cardiovascular injuries
including our hind limb ischemia model [25–27].
Anti-inflammatory medications currently available for clinical
use include glucorticoid drugs such as dexamethasone. Dexa-
methasone binds the glucocorticoid receptor, which subsequently
translocates to the nucleus and represses inflammatory gene
expression by inhibiting e.g. NF-kB activity [4,5,42]. To compare
the efficacy of SOD3 mediated anti-inflammatory effect to existing
medication we determined the effect of Dexamethasone in mouse
peritonitis. As a dose of 50 mg/kg, dexamethasone reduced
leukocyte traffic in comparable levels to SOD3 gene transfer
(Figure 4A). Dexamethasone-mediated effect was equally effective
in monocyte/macrophage and lymphocyte lineages whereas no
significant effect was seen in neutrophils (Figure 4B). Neutrophil
Figure 5. SOD3-mediated reduction in activity of inflammatory
mediators. Open bars represent LacZ tissue and black bars represent
SOD3 animals. (a) Luciferase assay shows 50% reduction in NF-kB
activity in vitro, and western blot analysis shows increased IkBa
expression. (b) Quantitative RT-PCR analysis for cytokines and
chemokines. SOD3 overexpression derived reduced expression of TNFa,
IL-1a, IL-6, MCP-1, and MIP2 in injured tissue. (b) Analysis of ICAM,
VCAM, P-selectin, and E-selectin expression. Expression of inflammatory
adhesion molecules was significantly reduced in SOD3 muscle.
doi:10.1371/journal.pone.0005786.g005
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4 hours after induction of inflammation in zymosan induced
peritonitis [50]. Therefore, lack of effect on neutrophil migration
could be due to late time point analyzed. The data suggests that
SOD3 overexpression and dexamethasone administration have
similar anti-inflammatory effect in acute inflammation and
therefore suggesting SOD3 as a potential candidate molecule for
clinical treatments.
NF-kB plays a crucial role in mediating inflammation due to its
role in activating expression of pro-inflammatory genes such as
cytokines TNFa and IL1a, and adhesion molecules ICAM-1 and
VCAM-1 [43,44]. Since NF-kB is a redox sensitive transcription
factor being activated by oxidative stress, [12,13] we analyzed the
effect of SOD3 on NF-kB activity in vitro and showed significantly
decreased activity. (Figure 5A). The data is in line with previous
work in cardiovascular and liver transplantation models showing
that increased NAPDH oxidase-derived superoxide production
correlates with increased NF-kB activity, which is attenuated by
SOD3 overexpression [51–54].
Since cytokines TNFa, IL1a, IL6, MIP2, and MCP1 are known
to contain NF-kB binding sites in their gene promoters and are
thus up-regulated by NF-kB activation [55–61], we analyzed their
expression levels in rat muscle by quantitative PCR. All of the
analyzed cytokines and chemokines were significantly down-
regulated in SOD3 animals as compared to LacZ control animals
(Figure 5B). TNFa, IL1a, and IL6 promote inflammatory cell
migration by up-regulating E-selectin, P-selectin, ICAM, and
VCAM. Furthermore, macrophage recruitment has been shown
to be strongly dependent on MCP-1 secretion [46], while MIP2 is
a strong attractant for neutrophils [35]. MCP-1 deficiency does
not reduce the number of resident macrophages in peritoneal
cavity, but prevents macrophage migration in response to acute
thioglycollate induced peritonitis [46]. Lu et al. showed 3-fold
reduction in macrophage migration in 2,4-dinitro-1-fluorobenzene
induced skin hypersensitivity model while neutrophil numbers
remained unchanged. Thereafter, marked down-regulation of
MCP-1 seen in ischemic muscle could explain the observed strong
macrophage inhibition. Finally, due to reduced inflammatory
cytokine expression, we conducted further expression analyses and
found reduced expression VCAM, ICAM, E-selectin, and P-
selectin (Figure 5C). Reduced expression of common adhesion
molecules highlights the anti-migratory role of SOD3. It has been
shown that macrophage transmigration is strongly dependent on
a4b1 integrin - ICAM-1 interaction. Pre-treatment of recipient
mice before intra venous macrophage injection with monoclonal
antibodies for ICAM-1 reduced macrophage migration to
atherosclerotic plaques by 65% [62]. In addition, rolling and
attachment of P388D1 mouse monocyte cell line was inhibited by
P-selectin and VCAM antibodies in an ex vivo isolated perfused
carotid artery model [63] demonstrating the importance of these
adhesion molecules on macrophage transmigration.
In conclusion, our novel observation shows that SOD3 gene
transfer into hind limb ischemia or peritonitis results in
significantly reduced leukocyte migration due to decreased
cytokine and adhesion molecule expression. Further on, the data
suggest more pronounced anti-inflammatory effect on macro-
phages as compared to other leukocyte subtypes in the models
used in the current work. The observed anti-inflammatory effect in
SOD3 treated mice was comparable or even higher than that of
Dexamethasone, which recently has been shown to have
cardiovascular side effects [64,65]. Our previous in vivo SOD3
overexpression models have suggested non-toxicity and beneficial
effect on tissue protection and injury recovery [24–26,31]
suggesting that SOD3 overexpression by exogenous administra-
tion or through increased endogenous production in injured tissues
could provide a promising medication against excess inflammatory
cell migration.
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